TrialHeadache2015

Long-term efficacy of a double-blind, placebo-controlled, randomized study for repetitive sphenopalatine blockade with bupivacaine vs. saline with the Tx360 device for treatment of chronic migraine.

Roger K Cady et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.